BIODESIX INC
For the period ended Feb 26, 2026. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Feb 26, 2026 · Filed Feb 26, 2026
Use the contents to explore the available documents and sections.
BDSX$8.53-57.0%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except share data)
(in thousands, except share data)
| December 31, 2025 | December 31, 2024 | |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $18,987 | $26,245 |
| Accounts receivable, net of allowance for credit losses of $62 and $481 | 9,036 | 8,603 |
| Other current assets | 4,495 | 4,636 |
| Total current assets | 32,518 | 39,484 |
| Non‑current assets | ||
| Property and equipment, net | 24,817 | 27,828 |
| Intangible assets, net | 3,883 | 5,874 |
| Operating lease right-of-use assets | 2,997 | 1,767 |
| Goodwill | 15,031 | 15,031 |
| Other long-term assets | 8,230 | 7,260 |
| Total non‑current assets | 54,958 | 57,760 |
| Total assets | $87,476 | $97,244 |
| Liabilities and Stockholders' (Deficit) Equity | ||
| Current liabilities | ||
| Accounts payable | $3,080 | $2,194 |
| Accrued liabilities | 11,033 | 10,064 |
| Deferred revenue | 961 | 678 |
| Current portion of operating lease liabilities | 1,364 | 719 |
| Current portion of notes payable | 6 | 21 |
| Other current liabilities | 992 | 641 |
| Total current liabilities | 17,436 | 14,317 |
| Non‑current liabilities | ||
| Long‑term notes payable, net of current portion | 47,445 | 36,408 |
| Long-term operating lease liabilities | 24,039 | 24,828 |
| Other long-term liabilities | 1,021 | 815 |
| Total non‑current liabilities | 72,505 | 62,051 |
| Total liabilities | 89,941 | 76,368 |
| Commitments and contingencies | ||
| Stockholders’ (deficit) equity | ||
| Preferred stock, $0.001 par value, 5,000,000 authorized; 0 (2025 and 2024) issued and outstanding | — | — |
| Common stock, $0.001 par value, 200,000,000 authorized; 8,253,053 (2025) and 7,274,578 (2024) shares issued and outstanding | 8 | 7 |
| Additional paid‑in capital | 495,289 | 483,366 |
| Accumulated deficit | (497,762) | (462,497) |
| Total stockholders’ (deficit) equity | (2,465) | 20,876 |
| Total liabilities and stockholders’ (deficit) equity | $87,476 | $97,244 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.